GPT and metabolic dysfunction-associated steatotic liver disease: Although ALT is recommended in clinical guidelines as a cost-effective and accessible screening tool for pediatric NAFLD, its utility is limited by low sensitivity and its inability to directly reflect underlying metabolic dysfunction [44, 45].